Nocturnal Parkinson's Disease Symptoms Study Group
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01662427 |
Recruitment Status
:
Completed
First Posted
: August 10, 2012
Last Update Posted
: August 20, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Parkinson's Disease | Other: Questionaire to assess Noctural Parkinson's Disease Symptoms |
Study Type : | Observational |
Actual Enrollment : | 300 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Nocturnal Parkinson's Disease Symptoms Study Group |
Study Start Date : | November 2012 |
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |

Group/Cohort | Intervention/treatment |
---|---|
Questionniare |
Other: Questionaire to assess Noctural Parkinson's Disease Symptoms
Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life
|
- To assess Noctural Parkinson's Disease Symptoms
- To assess quality of life in Parkinson's Disease patient
- To assess quality of life in caregiver of Parkinson's Disease patient

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 90 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Idiopathic Parkinson's disease patient
Exclusion Criteria:
- Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
- Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
- Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01662427
Thailand | |
Roongroj Bhidayasiri | |
Pathumwan, Bangkok, Thailand, 10330 |
Responsible Party: | Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University |
ClinicalTrials.gov Identifier: | NCT01662427 History of Changes |
Other Study ID Numbers: |
6222012 |
First Posted: | August 10, 2012 Key Record Dates |
Last Update Posted: | August 20, 2013 |
Last Verified: | August 2013 |
Keywords provided by Roongroj Bhidayasiri, Chulalongkorn University:
Quality of life Noctural Parkinson's Disease Symptoms |
Additional relevant MeSH terms:
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |